These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 9345046)
21. Comparison of the immunogenicity of two inactivated recombinant rabies viruses overexpressing the glycoprotein. Navid MT; Li Y; Zhou M; Cui M; Fu ZF; Tang L; Zhao L Arch Virol; 2016 Oct; 161(10):2863-70. PubMed ID: 27438075 [TBL] [Abstract][Full Text] [Related]
22. Glycoprotein from street rabies virus BD06 induces early and robust immune responses when expressed from a non-replicative adenovirus recombinant. Wang S; Sun C; Zhang S; Zhang X; Liu Y; Wang Y; Zhang F; Wu X; Hu R Arch Virol; 2015 Sep; 160(9):2315-23. PubMed ID: 26143474 [TBL] [Abstract][Full Text] [Related]
23. Antibody cross-competition analysis of the human immunodeficiency virus type 1 gp120 exterior envelope glycoprotein. Moore JP; Sodroski J J Virol; 1996 Mar; 70(3):1863-72. PubMed ID: 8627711 [TBL] [Abstract][Full Text] [Related]
24. Evidence from the anti-idiotypic network that the acetylcholine receptor is a rabies virus receptor. Hanham CA; Zhao F; Tignor GH J Virol; 1993 Jan; 67(1):530-42. PubMed ID: 7677960 [TBL] [Abstract][Full Text] [Related]
25. CD4-imitating human antibodies in HIV infection and anti-idiotypic vaccination. Deckert PM; Ballmaier M; Lang S; Deicher H; Schedel I J Immunol; 1996 Jan; 156(2):826-33. PubMed ID: 8543839 [TBL] [Abstract][Full Text] [Related]
26. Human immunodeficiency virus type 1 gp120 C5 region mimics the HLA class I alpha 1 peptide-binding domain. Lopalco L; De Santis C; Meneveri R; Longhi R; Ginelli E; Grassi F; Siccardi AG; Beretta A Eur J Immunol; 1993 Aug; 23(8):2016-21. PubMed ID: 8344367 [TBL] [Abstract][Full Text] [Related]
27. Antipeptide monoclonal antibodies inhibit the binding of rabies virus glycoprotein and alpha-bungarotoxin to the nicotinic acetylcholine receptor. Bracci L; Antoni G; Cusi MG; Lozzi L; Niccolai N; Petreni S; Rustici M; Santucci A; Soldani P; Valensin PE Mol Immunol; 1988 Sep; 25(9):881-8. PubMed ID: 3062388 [TBL] [Abstract][Full Text] [Related]
28. Localization of rabies virus glycoprotein into the endoplasmic reticulum produces immunoprotective antigen. Yadav DK; Ashraf S; Singh PK; Tuli R Protein J; 2012 Aug; 31(6):447-56. PubMed ID: 22592449 [TBL] [Abstract][Full Text] [Related]
29. Immune response to neonatal genetic immunization. Wang Y; Xiang Z; Pasquini S; Ertl HC Virology; 1997 Feb; 228(2):278-84. PubMed ID: 9123835 [TBL] [Abstract][Full Text] [Related]
30. G glycoprotein amino acid residues required for human monoclonal antibody RAB1 neutralization are conserved in rabies virus street isolates. Wang Y; Rowley KJ; Booth BJ; Sloan SE; Ambrosino DM; Babcock GJ Antiviral Res; 2011 Aug; 91(2):187-94. PubMed ID: 21693135 [TBL] [Abstract][Full Text] [Related]
31. A monoclonal antibody to a synthetic fragment of rabies virus glycoprotein binds ligands of the nicotinic cholinergic receptor. Rustici M; Santucci A; Lozzi L; Petreni S; Spreafico A; Neri P; Bracci L; Soldani P J Mol Recognit; 1989 Sep; 2(2):51-5. PubMed ID: 2636896 [TBL] [Abstract][Full Text] [Related]
32. Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus. Xiang ZQ; Spitalnik S; Tran M; Wunner WH; Cheng J; Ertl HC Virology; 1994 Feb; 199(1):132-40. PubMed ID: 8116236 [TBL] [Abstract][Full Text] [Related]
34. Human infection due to recombinant vaccinia-rabies glycoprotein virus. Rupprecht CE; Blass L; Smith K; Orciari LA; Niezgoda M; Whitfield SG; Gibbons RV; Guerra M; Hanlon CA N Engl J Med; 2001 Aug; 345(8):582-6. PubMed ID: 11529212 [No Abstract] [Full Text] [Related]
35. [Production of monoclonal antibodies against a wild strain of rabies virus]. Akacem O; Benmansour A; Coulon P; Brahimi M; Benhassine M Arch Inst Pasteur Alger; 1992; 58():283-90. PubMed ID: 1309144 [TBL] [Abstract][Full Text] [Related]
36. A DNA vaccine that encodes rabies virus glycoprotein lacking transmembrane domain enhances antibody response but not protection. Gupta PK; Sharma S; Walunj SS; Patil AA; Rai A; Saini M Acta Virol; 2006; 50(2):87-92. PubMed ID: 16808325 [TBL] [Abstract][Full Text] [Related]
37. Induction of protective immunity by topic application of a recombinant adenovirus expressing rabies virus glycoprotein. Lees CY; Briggs DJ; Wu X; Davis RD; Moore SM; Gordon C; Xiang Z; Ertl HC; Tang DC; Fu ZF Vet Microbiol; 2002 Apr; 85(4):295-303. PubMed ID: 11856579 [TBL] [Abstract][Full Text] [Related]
38. Mapping and characterization of a sequential epitope on the rabies virus glycoprotein which is recognized by a neutralizing monoclonal antibody, RG719. Ni Y; Tominaga Y; Honda Y; Morimoto K; Sakamoto S; Kawai A Microbiol Immunol; 1995; 39(9):693-702. PubMed ID: 8577283 [TBL] [Abstract][Full Text] [Related]
39. A sindbis virus replicon-based DNA vaccine encoding the rabies virus glycoprotein elicits immune responses and complete protection in mice from lethal challenge. Saxena S; Dahiya SS; Sonwane AA; Patel CL; Saini M; Rai A; Gupta PK Vaccine; 2008 Dec; 26(51):6592-601. PubMed ID: 18848857 [TBL] [Abstract][Full Text] [Related]
40. Comparison of the protective efficacy between single and combination of recombinant adenoviruses expressing complete and truncated glycoprotein, and nucleoprotein of the pathogenic street rabies virus in mice. Kim HH; Yang DK; Nah JJ; Song JY; Cho IS Virol J; 2017 Jun; 14(1):122. PubMed ID: 28646885 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]